Sort
51,593 grants matching “hepatitis”
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$1,030,984Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2016 · HL
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$1,030,748Catherine C McGowan · Vanderbilt University · U01 · FY2015 · AI
Establishment/Maintenance of Biomedical Research Colony
$1,030,597Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2009 · RR
Development of Hepatitis C Virus Inhibitors
$1,030,553Glen Andrew Coburn · Progenics Pharmaceuticals, Inc. · R44 · FY2007 · AI
Structural Biology Of Virus Assembly
$1,030,437Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · Z01 · FY2008 · AR
Saline Enhanced Radiofrequency Ablation for Liver Tumors
$1,030,412Michael G Curley · Thermedical, Inc. · R44 · FY2007 · CA
HIV Disease Outcomes in Drug Users in Clinical Practice
$1,029,864Johns Hopkins University · R01 · FY2005 · DA
UCSF HIV Clinical Trials Unit
$1,028,280Diane V Havlir · University Of California, San Francisco · U01 · FY2008 · AI
Application Of Mass Spectrometry To Structural Biology
$1,028,098Kenneth Tomer · Environmental Health Sciences · Z01 · FY2007 · ES
ASIAN AMERICAN NETWORK FOR CANCER AWAREN. RESEARCH & TRG
$1,027,996Moon S Chen · University Of California At Davis · U01 · FY2006 · CA
Acute Hepatitis C Infection in Young Injectors
$1,027,825Kimberly Page · University Of California, San Francisco · R01 · FY2012 · DA
The PIP2-virus interface and PI 4-kinase: novel biology and validation targets
$1,027,579Jeffrey S Glenn · Stanford University · R01 · FY2015 · AI
PROJECT 2:Structural studies of SOSIP trimers
$1,027,402Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2020 · AI
Ethical, Legal and Social Issues for Precision Medicine and Infectious Disease
$1,027,331Gail Geller · Johns Hopkins University · RM1 · FY2017 · HG
Gulf Longitudinal Follow-up (GuLF) Study
$1,026,914Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2013 · ES
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$1,026,858Suwat Chariyalertsak · Chiang Mai University · UM1 · FY2017 · AI
Studies of Rare Cancers
$1,026,691Katherine McGlynn · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Defining Natural History and Optimal Treatment Outcome for Chronic HBV Infection
$1,026,532Norah A. Terrault · University Of California, San Francisco · U01 · FY2013 · DK
Administrative Core
$1,025,924Craig J McClain · University Of Louisville · P20 · FY2024 · GM
CIP Genomics Core
$1,025,863Colm Ohuigin · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)
$1,025,696Christine Marie Durand · Johns Hopkins University · U01 · FY2022 · AI
An innovative, non-thiazolidinedione pan-PPAR agonist therapeutic for alcoholic hepatitis: IND-enabling safety and toxicological evaluation
$1,025,643Prasad Manchem · Pleiogenix Inc. · R44 · FY2025 · AA
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$1,024,796Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study
$1,023,762Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
HIV AND THE SEXUAL NETWORKS OF IDUS AND DRUG-USING MSM
$1,023,683Lawrence J Ouellet · University Of Illinois At Chicago · U01 · FY2006 · DA